Cargando…
Chemical parsing: Dissecting cell dependencies with a toolkit of selective BCL-2 family inhibitors
The BCL-2/BCL-X(L) inhibitor navitoclax has shown promise for the treatment of cancer but on-target toxicities have limited its utility. Recently, the generation of selective BCL-2 family inhibitors has enabled a careful dissection of BCL-2 biology, and early work indicates that these molecules have...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845185/ https://www.ncbi.nlm.nih.gov/pubmed/27308564 http://dx.doi.org/10.1080/23723556.2015.1050155 |